Wang Jing, Li Yiye, Nie Guangjun
CAS Key Laboratory for Biomedical Effects of Nanomaterials & Nanosafety, CAS Center for Excellence in Nanoscience, National Center for Nanoscience and Technology, China, Beijing, China.
Center of Materials Science and Optoelectronics Engineering, University of Chinese Academy of Sciences, Beijing, China.
Nat Rev Mater. 2021;6(9):766-783. doi: 10.1038/s41578-021-00315-x. Epub 2021 May 19.
Biomolecule-based nanostructures are inherently multifunctional and harbour diverse biological activities, which can be explored for cancer nanomedicine. The supramolecular properties of biomolecules can be precisely programmed for the design of smart drug delivery vehicles, enabling efficient transport in vivo, targeted drug delivery and combinatorial therapy within a single design. In this Review, we discuss biomolecule-based nanostructures, including polysaccharides, nucleic acids, peptides and proteins, and highlight their enormous design space for multifunctional nanomedicines. We identify key challenges in cancer nanomedicine that can be addressed by biomolecule-based nanostructures and survey the distinct biological activities, programmability and in vivo behaviour of biomolecule-based nanostructures. Finally, we discuss challenges in the rational design, characterization and fabrication of biomolecule-based nanostructures, and identify obstacles that need to be overcome to enable clinical translation.
基于生物分子的纳米结构具有内在的多功能性,并具有多种生物活性,可用于癌症纳米医学。生物分子的超分子特性可以被精确编程,以设计智能药物递送载体,实现体内高效运输、靶向药物递送以及在单一设计中的联合治疗。在本综述中,我们讨论了基于生物分子的纳米结构,包括多糖、核酸、肽和蛋白质,并强调了它们在多功能纳米医学方面巨大的设计空间。我们确定了基于生物分子的纳米结构可以解决的癌症纳米医学中的关键挑战,并概述了基于生物分子的纳米结构独特的生物活性、可编程性和体内行为。最后,我们讨论了基于生物分子的纳米结构的合理设计、表征和制造方面的挑战,并确定了实现临床转化需要克服的障碍。